Journal of Innovative Pharma and Drug Sciences
Peer Reviewed Open Access Journal
Peer Reviewed Open Access Journal
The Journal of Innovative Pharma and Drug Sciences publishes high-quality original research, reviews, and scholarly contributions across the full spectrum of pharmaceutical sciences and drug research. The journal emphasizes interdisciplinary, translational, and application-oriented studies that support innovation in healthcare and pharmaceutical development.
Research on formulation design, dosage forms, controlled and sustained release systems, novel drug delivery technologies, transdermal systems, pulmonary and ocular delivery, and patient-centric formulations.
Studies involving drug design, synthesis, structure–activity relationships, molecular modeling, chemical biology, and optimization of small molecules and therapeutic agents.
Experimental and clinical research on drug action, mechanisms of action, receptor pharmacology, preclinical pharmacology, safety evaluation, toxicological profiling, and risk assessment.
Research on medicinal plants, marine and microbial natural products, phytochemistry, extraction and isolation of bioactive compounds, standardization, and biological evaluation of natural products.
Studies related to patient-oriented pharmacy practice, pharmaceutical care, drug therapy management, medication adherence, pharmacoeconomics, and outcomes research in clinical settings.
Research covering biopharmaceuticals, recombinant therapeutics, vaccines, gene and cell therapies, bioprocessing, bioavailability, and biopharmaceutical evaluation.
Innovative research on target identification, lead discovery, preclinical development, translational research, and integration of computational and experimental drug development approaches.
Studies on analytical method development and validation, pharmaceutical quality control, stability studies, impurity profiling, and compliance with pharmacopeial standards.
Research addressing regulatory frameworks, drug approval processes, regulatory science, intellectual property rights, pharmacoeconomics, healthcare policies, and global regulatory harmonization.
Experimental and modeling studies on drug absorption, distribution, metabolism, and excretion (ADME), dose–response relationships, population pharmacokinetics, and PK/PD modeling.
Research on adverse drug reactions, post-marketing surveillance, risk management plans, signal detection, medication errors, and drug safety assessment.
Studies related to scale-up, manufacturing technologies, process optimization, validation, quality by design (QbD), and good manufacturing practices (GMP).
Research on formulation, standardization, safety, efficacy, and scientific validation of herbal medicines, traditional systems of medicine, and integrative therapeutic approaches.
Studies involving nanoparticles, nanoemulsions, liposomes, polymeric carriers, nanocrystals, and nanomedicine applications for enhanced therapeutic outcomes.
Research on molecular-level drug interactions, targeted drug delivery, precision medicine, biomarker-based therapies, and advanced therapeutic strategies.
Research on bioavailability and bioequivalence studies, clinical trial design, data analysis, ethical considerations, clinical research methodologies, and regulatory compliance.
With a strong focus on scientific excellence, innovation, regulatory relevance, and clinical applicability, the Journal of Pharmacy and Drug Research aims to promote knowledge dissemination and advance pharmaceutical research for improved healthcare outcomes.